CERVICAL CANCER (SB) Flashcards

1
Q

What are the primary risk factors for cervical cancer?

A

Early onset and frequent sexual contact, multiple sexual partners, history of STI, HPV infection, OCP use, smoking (SCCA), history of vulvar or vaginal dysplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common sexually transmitted infection associated with cervical cancer?

A

Human papillomavirus (HPV).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of virus is HPV?

A

Double-stranded DNA virus that replicates within epithelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which HPV types are considered high risk and responsible for more than 70% of cervical cancers?

A

HPV 16 and HPV 18.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the three types of HPV vaccines?

A

Bivalent (Cervarix), Quadrivalent (Gardasil), and Nonavalent (Gardasil 9).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

At what ages is HPV vaccination recommended?

A

Boys and girls aged 11-12 years (as early as 9 years), with catch-up vaccination recommended for females aged 13-26 who have not been previously vaccinated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the primary method of secondary prevention for cervical cancer?

A

Pap smear and HPV testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Between what ages should routine cervical cancer screening be performed?

A

Ages 21-65.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the recommended screening for women aged 21-29 years?

A

Pap testing every 3 years, no HPV testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the recommended screening for women aged 30-65 years?

A

Co-testing with Pap and HPV testing every 5 years (preferred) or Pap testing alone every 3 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Under what conditions can cervical cancer screening be discontinued in women over 65?

A

Three consecutive negative Pap smears or two consecutive negative HPV tests with no history of CIN 2+ in the past 20 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the transformation zone in the cervix, and why is it significant?

A

The transformation zone is the area where the squamous epithelium of the ectocervix meets the columnar epithelium of the endocervix; it is the site where cervical cancer commonly develops.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is cervical intraepithelial neoplasia (CIN)?

A

A histologic diagnosis of precancerous lesions in the squamous epithelium of the cervix, graded as CIN 1, 2, or 3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which CIN grade is most likely to regress spontaneously?

A

CIN 1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which CIN grade is a precursor to invasive cancer?

A

CIN 3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the histologic characteristic of CIN 3?

A

Cellular atypia involves more than two-thirds of the epithelial layer with an increased nucleus-to-cytoplasm ratio and rapid cell division.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the significance of atypical squamous cells of undetermined significance (ASC-US) on a Pap smear?

A

Atypical cells are present, but their significance is unclear. Follow-up includes repeat cytology at 12 months or HPV testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What should be done if a patient has ASC-US and a positive HPV test?

A

Perform colposcopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the preferred management for a patient with ASC-H (atypical squamous cells - cannot exclude high-grade lesion)?

A

Colposcopy to evaluate for CIN 2/3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the histologic correlation of low-grade squamous intraepithelial lesion (LSIL)?

A

LSIL is consistent with CIN 1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the management for a patient with LSIL and a negative HPV test?

A

Repeat HPV and Pap testing in 1 year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the next step for a patient with LSIL and a positive HPV test?

A

Perform colposcopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the recommended management for CIN that persists for more than 2 years?

A

Excision procedure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What percentage of unmanaged CIN 2/3 cases progress to cervical cancer?

A

0.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the next step in the management of high-grade squamous intraepithelial lesion (HSIL)?

A

Colposcopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the treatment options for HSIL depending on age and biopsy results?

A

Excision or ablation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What percentage of Pap tests show atypical glandular cells (AGC)?

A

Approximately 3 out of every 1000 Pap tests.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the risk of underlying invasive cancer in patients with atypical glandular cells?

A

3% to 17%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the recommended evaluation for atypical glandular cells (AGC)?

A

Colposcopy with endocervical sampling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What additional test should be performed for patients over 35 years old with AGC?

A

Endometrial sampling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What risk factors indicate the need for endometrial sampling in AGC?

A

Unexplained vaginal bleeding, obesity, chronic anovulation (e.g., PCOS), or family history of Lynch syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the first step in evaluating women with abnormal cytology?

A

Colposcopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is a colposcope?

A

A low-power binocular microscope with a light source used to examine the cervix.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What solution is applied to the cervix during colposcopy to highlight abnormal areas?

A

Diluted 3-5% acetic acid.

35
Q

What does an acetowhite lesion on colposcopy indicate?

A

Possible dysplastic or cancerous cells.

36
Q

Why do dysplastic cells appear white after applying acetic acid?

A

Acetic acid dehydrates epithelial cells; dysplastic cells with large nuclei reflect light and appear white.

37
Q

When is a colposcopy considered ‘satisfactory’?

A

When the entire transformation zone is visible and assessed.

38
Q

What is recommended if a colposcopy is ‘unsatisfactory’?

A

Endocervical curettage (ECC).

39
Q

What are common hemostatic agents used after a cervical biopsy?

A

Ferric subsulfate (Monsel’s solution) or silver nitrate sticks.

40
Q

What are the two main types of treatment for cervical dysplasia?

A

Ablative and excisional procedures.

41
Q

What are the common ablative treatments for cervical dysplasia?

A

Cryotherapy and CO2 laser ablation.

42
Q

What is the most common method of excisional treatment for cervical dysplasia?

A

Loop Electrosurgical Excision Procedure (LEEP).

43
Q

What is the purpose of cold knife conization?

A

To excise the cervix for histopathologic examination and ensure clear margins.

44
Q

What is the most common histologic type of cervical cancer?

A

Squamous cell carcinoma (SCCA).

45
Q

What are the subtypes of squamous cell carcinoma of the cervix?

A

Large cell (keratinized or non-keratinizing), small cell, and verrucous carcinoma.

46
Q

What is the significance of verrucous carcinoma of the cervix?

A

Rare, resembles vulvar warty tumors, rarely metastasizes unless mixed with typical SCCA.

47
Q

What are the subtypes of adenocarcinoma of the cervix?

A

Endocervical, endometrioid, clear cell, adenoid cystic, and adenoma malignum.

48
Q

What is the worst prognostic subtype of adenocarcinoma?

A

Clear cell adenocarcinoma.

49
Q

Which cervical adenocarcinoma subtype is associated with diethylstilbestrol (DES) exposure?

A

Clear cell adenocarcinoma.

50
Q

What is the significance of adenoid cystic carcinoma of the cervix?

A

Aggressive, resembles basal cell carcinoma, more common in women over 60.

51
Q

What is adenoma malignum (minimal deviation adenocarcinoma)?

A

A rare, highly invasive mucinous adenocarcinoma with early metastasis.

52
Q

What is the mixed histologic type of cervical cancer?

A

Adenosquamous carcinoma.

53
Q

What is a particularly aggressive form of adenosquamous carcinoma?

A

Glassy cell carcinoma.

54
Q

Why is glassy cell carcinoma considered highly aggressive?

A

It metastasizes early to lymph nodes and distant sites, often leading to poor outcomes.

55
Q

What are the common clinical presentations of cervical cancer?

A

Abnormal bleeding, abnormal discharge, intermenstrual bleeding, postcoital bleeding, foul-smelling vaginal discharge.

56
Q

What are the three biopsy tools used for diagnosing cervical cancer?

A

Kevorkian, Eppendorf, Tischler.

57
Q

What imaging and diagnostic tests are used in clinical staging of cervical cancer?

A

Physical exam, chest X-ray (CXR), intravenous pyelography (IVP), CT scan.

58
Q

What is FIGO Stage 1 cervical cancer?

A

Cancer is confined to the cervix.

59
Q

What is FIGO Stage 2 cervical cancer?

A

Cancer has spread to the uterus, kidneys, or lower third of the vagina.

60
Q

What is FIGO Stage 3 cervical cancer?

A

Cancer has spread to lymph nodes.

61
Q

What is FIGO Stage 4 cervical cancer?

A

Cancer has metastasized to distant organs.

62
Q

What is the most common lymph node metastasis site for cervical cancer?

A

Parametrial lymph nodes.

63
Q

What are the three macroscopic appearances of cervical cancer?

A

Ulcerated, exophytic (cauliflower-like), endophytic.

64
Q

What is an endophytic cervical tumor?

A

A deeply invasive tumor that originates from the endocervix, filling the cervix and lower uterine segment (barrel-shaped cervix).

65
Q

What are the most important prognostic factors for cervical cancer?

A

Tumor size, lymph node involvement, and FIGO stage.

66
Q

What is the significance of tumor diameter in FIGO staging of stage I cervical cancer?

A

Stage IB1 is ≤4 cm, Stage IB2 is >4 cm.

67
Q

What is the primary management for Stage I-IIA cervical cancer?

A

Radical hysterectomy with bilateral lymphadenectomy or radiation therapy.

68
Q

What is the main treatment for Stage IIB, III, and IVA cervical cancer?

A

Chemoradiation.

69
Q

When is neoadjuvant chemotherapy used in cervical cancer?

A

Before surgery or radiation therapy.

70
Q

When is extended field radiation used in cervical cancer treatment?

A

When there is paraaortic lymph node involvement.

71
Q

What is the recommended follow-up schedule for cervical cancer survivors in the first 5 years?

A

Every 3 months for the first 2 years, every 6 months from years 3-5, then yearly after 5 years.

72
Q

What tests are included in follow-up monitoring for cervical cancer?

A

Physical exam, Pap smear, CXR, PET scan, renal function test.

73
Q

When do most cervical cancer recurrences occur?

A

Within 2 years.

74
Q

What is the main treatment for pelvic recurrence of cervical cancer?

A

Chemoradiation.

75
Q

What is pelvic exenteration?

A

An extensive surgical procedure for central pelvic tumor recurrence when curative treatment is possible.

76
Q

What is anterior pelvic exenteration?

A

Removal of the bladder, uterus, cervix, and all or part of the vagina.

77
Q

What is posterior pelvic exenteration?

A

Removal of the anus, rectum, uterus, cervix, and all or part of the vagina.

78
Q

What is total pelvic exenteration?

A

Removal of all pelvic contents.

79
Q

When is pelvic exenteration NOT performed?

A

For palliative purposes.

80
Q

What percentage of cervical cancer recurrences occur in the pelvis?

A

Approximately 50%.

81
Q

What imaging modality is useful in assessing pelvic recurrence?

A

Vaginal ultrasound scan.

82
Q

What are the treatment options for non-pelvic recurrence of cervical cancer?

A

Radiation, surgery, chemotherapy.

83
Q

When can localized non-pelvic recurrences be treated with radiation?

A

When they occur in areas not previously irradiated.

84
Q

When is metastasis resection considered in cervical cancer recurrence?

A

When a solitary metastasis occurs 3-4 years after primary therapy.